Pharmacokinetics and tissue distribution of minocycline hydrochloride in horses.

The research details the pharmacokinetics and tissue distribution of minocycline administered intravenously in horses, showing its effectiveness in treating various infections, including those in the central nervous system.

Research Method and Objectives

• This study is aimed at determining how minocycline hydrochloride, an antibiotic, is absorbed, distributed, metabolized, and eliminated by the horse’s body.
• It’s specifically designed to assess the pharmacokinetics and tissue distribution of the drug when administered intravenously to horses.
• The researchers used five healthy Thoroughbred mares for studying pharmacokinetics and another six mares for the tissue distribution experiment.
• Each mare was administered an intravenous dosage of 2.2 mg of minocycline hydrochloride per kg of body weight.
• For the pharmacokinetics study, blood samples were taken at eleven points in time, before and within 48 hours after the administration of the drug.
• The tissue distribution was studied by analysing 24 different tissue samples taken at half an hour and three hours after administration.

Findings of the Study

• The study did not observe any adverse effects in the horses following the administration of minocycline.
• It found that the average elimination half-life of the drug was roughly 7.70 hours, meaning that it takes around that time for half of the drug to be eliminated from the body.
• The total body clearance, indicating the volume of blood from which the drug is completely removed per unit time, was measured at 0.16 litres per hour per kg.
• The volume absorbed by the body at a steady state was roughly 1.53 litres per kg. This indicates how well-distributed the drug is throughout the body, acting as an indicator of how well it can reach various body tissues.
• The amount of the drug bound to plasma proteins was 68.1%, with such binding often influencing a drug’s distribution and elimination in the body.
• Free minocycline (not bound to plasma proteins) was detected in the plasma at a concentration of 0.12 micrograms/mL at 12 hours post-administration.
• At half an hour after drug administration, minocycline was not detected in the brain tissue, cerebrospinal fluid, or the eye’s aqueous humor. However, it was found in these tissues, except the aqueous humor, three hours after administration.

Conclusions and Implications

• The clearance rate of minocycline in healthy mares was found to be higher than that of humans, reflecting species differences in drug metabolism and elimination.
• For effectively treating infections in horses with common equine pathogens, the study recommends administering minocycline at a dosage of 2.2 mg/kg intravenously every 12 hours. This dosing strategy would maintain effective drug concentrations in the horse’s body.
• The study suggests that the drug could be useful for treating infections in various horse tissues, including the central nervous system (CNS).
• Overall, the study’s findings contribute to better understanding minocycline’s pharmacokinetics in horses and its potential use for equine therapy, aiding in its appropriate use.